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Case report Acute lyme infection presenting with amyopathic 
dermatomyositis and rapidly fatal interstitial 
pulmonary fibrosis: a case report
Hien Nguyen*1, Connie Le2 and Hanh Nguyen3
Abstract
Introduction: Dermatomyositis has been described in the setting of lyme infection in only nine previous case reports. 
Although lyme disease is known to induce typical clinical findings that are observed in various collagen vascular 
diseases, to our knowledge, we believe that our case is the first presentation of acute lyme disease associated with 
amyopathic dermatomyositis, which was then followed by severe and fatal interstitial pulmonary fibrosis only two 
months later.
Case presentation: We present a case of a 64-year-old African-American man with multiple medical problems who 
was diagnosed with acute lyme infection after presenting with the pathognomonic rash and confirmatory serology. In 
spite of appropriate antimicrobial therapy for lyme infection, he developed unexpected amyopathic dermatomyositis 
and then interstitial lung disease.
Conclusions: This case illustrates a potential for lyme disease to produce clinical syndromes that may be 
indistinguishable from primary connective tissue diseases. An atypical and sequential presentation (dermatomyositis 
and interstitial lung disease) of a common disease (lyme infection) is discussed. This case illustrates that in patients who 
are diagnosed with lyme infection who subsequently develop atypical muscular, respiratory or other systemic 
complaints, the possibility of severe rheumatological and pulmonary complications should be considered.
Introduction
Dermatomyositis has been described in the setting of
lyme infection in only nine previous case reports. Our
case is unique in the rapidity and severity of the subse-
quent fatal interstitial lung disease (ILD). In spite of a link
of dermatomyositis with varied medical conditions, its
pathogenesis remains elusive. Lyme disease is known to
induce a constellation of clinical symptoms which are
characteristic of various collagen vascular diseases. In
summary, we describe a novel and highly unusual case in
which the diagnosis of lyme infection was followed by
amyopathic dermatomyositis and then interstitial pulmo-
nary fibrosis.
Case presentation
A 64-year-old African-American man with prostate can-
cer, chronic obstructive pulmonary disease (COPD), and
hepatitis C virus (HCV) infection, presented with four
weeks of polyarthralgias of bilateral knees, hands, and
neck, which were preceded two weeks previously by a 5
cm annular lesion on his abdomen with central clearing
consistent with erythema migrans (EM). The lyme IgM
antibody testing was positive and consistent with acute
Borrelia burgdoferi infection, while all antibody bands for
B. burdorferi IgG were nonreactive. These results were
confirmed by western blot, with positive 25 and 41 KD
antibody IgM bands, in accordance with Centers for Dis-
ease Control's (CDC) diagnostic serologic criteria. Our
patient resided in Prince George's county in Maryland, an
endemic region for lyme infection in the eastern USA,
and it is suspected that infection occurred during fre-
quent outdoor exposures while mowing his lawn near a
wooded region. Normal laboratory values included C-
reactive protein, erythrocyte sedimentation rate, uric
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acid, rheumatoid factor (RF), antinuclear (ANA) and cit-
rulline antibodies, angiotensin converting enzyme, and
human immunodeficiency virus (HIV) antibody. Follow-
ing two weeks of doxycycline therapy for lyme infection
and steroids for polyarthralgias, he was subsequently
admitted with concurrent proximal muscle weakness of
lower and then upper extremities, progressive dyspnea,
facial and palmar dermatitis, and ten pound weight loss.
Physical examination of our patient revealed an ill
appearing, afebrile male, with respirations of 25/minute
and heart rate of 130/minute. Abnormal physical findings
included bibasilar crackles without wheezing; violaceous
skin eruption on the forehead, periorbital, and nasolabial
folds; hyperpigmented papular palms with cracked, ulcer-
ated fingertips; and decreased motor strength of 3/5 and
4/5 in the lower and upper extremities, respectively.
Laboratory evaluation included normal chemistry and
blood counts, mildly elevated transaminases, ANA 1:40,
positive anti JO-1 antibody, and negative cryoglobulins.
Creatine phosphokinase (CPK) and aldolase levels were
normal, which was suspected from recent corticosteroid
therapy versus amyopathic dermatomyositis. Magnetic
resonance imaging of the brain, lumbar spine and
extremities were normal. Skin biopsies of the facial and
finger lesions revealed advanced superficial and deep
perivascular lymphocytic infiltrates, pigmented mac-
rophages and perivascular lymphocytes in the superficial
dermis with vacuolar degeneration and dermal mucin.
The dermatopathologist felt that the clinicopathological
findings most favored a diagnosis of dermatomyositis.
Evaluation for severe dypsnea was unrevealing includ-
ing normal chest radiograph, nuclear stress testing, and
echocardiogram. A working differential diagnosis
revolved around the simultaneous occurrences of polyar-
thralgias and exuberant cutaneous and muscular symp-
toms, which could be related to his underlying HCV
infection, an emerging connective tissue disease, or pri-
mary lyme infection itself. A muscle biopsy was contem-
plated to further evaluate myositis and presence of
spirochetes. However, this was not completed due to our
patient's severe debility and opinion that such a workup
would not directly address the severe dyspnea, which was
his most concerning and life-threatening condition at
hand.
Repeat chest imaging confirmed bilateral ground glass
opacities, diffuse interstitial infiltrates, and no pulmonary
emboli on chest computed tomography scan. Our patient
underwent aggressive therapy including steroidal, antimi-
crobial, bronchodilator therapy, and intubation (it was
not completely clear the degrees to which his respiratory
decompensation was attributable to worsening COPD
exacerbation versus an interstitial pneumonitis, or pneu-
monia). His arterial blood glasses included pH 7.4, pCO 2
40, PO 2 104, CO 2 27 96% on BiPap with 100% FIO2. The
patient died one week later, and his family requested that
an autopsy not be performed.
Discussion
Lyme disease
As the most common tick-borne infection in the USA,
lyme disease manifests with clinical symptoms as early as
one week to several months after bacterial infection [1].
Characteristic clinical manifestations include erythema
migrans, cardiac and neuromuscular abnormalties, and
arthralgias. The severity of these symptoms may vary due
to complex interactions between the vector, bacteria, and
host factors which ultimately result in inflammatory cas-
cades (involving release of cytokines, chemokines, and
other immune modulators, which inflict significant unin-
tended host damage) [1]. Arthritis persists in ten percent
of cases in spite of adequate antimicrobial therapy [1].
Nardelli et al. theorize that disparities in disease severi-
ties of lyme infection in different hosts may be under-
stood in terms of genetic predispositions, immunologic
differences, autoimmunity, and coexistent medical prob-
lems [1]. There is an interesting example of this complex-
ity of interactions within a human with concurrent HCV
and lyme infection such as in our patient. Byrnes et al.
reported a male with chronic HCV infection, whose dis-
ease was eradicated following a life-threatening illness
f r o m  c o - i n f e c t i o n  w i t h  b a b e s i o s ,  l y m e  b o r r e l i o s i s ,  a n d
human granulocytic ehrlichiosis. They hypothesized that
an exuberant cellular immune response from the infec-
tions led to eradication of HCV [2].
Lyme disease diagnosis
Dermatomyositis has been described in the setting of
lyme infection in only nine previous case reports [3-5].
Although lyme antibody testing is generally fraught with
imprecise serological testing, either the pathognomonic
EM rash or confirmatory western blot meets the prereq-
uisites for the diagnosis of lyme infection per CDC crite-
ria [6]. Since both enzyme-linked immunosorbent assay
(ELISA) and western blot tests are indirect tests measur-
ing the immune system response to infection rather than
the bacteriologic agent itself, there are false positive
results that may be seen for example in rheumatoid con-
ditions [6]. False positive IgM antibody responses were
eliminated in our case by normal ANA, DNA, and RF
screens. Our case is unique because of the short time
period between the time of diagnosis of acute lyme infec-
tion and the onset of aymopathic dermatomyositis and
then severe and fatal pulmonary interstitial fibrosis.
Dermatomyositis diagnosis
The classic diagnostic criteria for dermatomyositis
described by Bohan included 1) skin lesions (heliotropic
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upper or lower extremities; 3) elevated CPK and 4) aldo-
lase levels; 5) myalgias; 6) abnormal electromyography; 7)
positive anti-Jo-1 antibody; 8) nondestructive arthralgias;
9) systemic inflammatory signs; and 10) Myositis [3-5].
Supporting studies include magnetic resonance imaging
and autoantibodies to nuclear and cytoplasmic antigens.
Other characteristic cutaneous findings include peri-
ungal erythema and telangiectasias; violaceous erythema
and edema of the face in a photosensitive distribution;
palmar panniculitis and hyperkeratosis (mechanic's
hands) (Figure 1) which is associated interestingly with
severe interstitial fibrosis as in our patient) [3-5]. Histo-
logical changes in dermatomyositis are likewise difficult
to distinguish from those observed in lupus, including
vacuolar changes of columnar epithelium, lymphocytic
inflammatory infiltrates at the dermal-epidermal inter-
face, and dermal mucin [3-5] (Figure 2).
Lyme disease association with dermatomyositis
The association of lyme disease and dermatomyositis has
been noted in only nine previous reports. In spite of a link
of dermatomyositis with other varied medical conditions
including infections, pregnancy, and medications
(hydroxyurea and penicillamine), its pathogenesis
remains elusive. Although our patient's medical condi-
tions included both malignancy and hepatitis C infection,
which are both associated with dermatomyositis, the
temporal onset of dermatomyositis coincided with the
time of diagnosis of acute lyme infection [7]. Steere et al.
noted that perivascular lymphoid infiltrates in clinical
myositis from lyme infection did not differ from polymy-
ositis or dermatomyositis, suggesting systemic autoim-
mune damage perhaps through formation of autobodies
cross-reacting with homologous host proteins in various
organ systems [8]. Inflammatory plasma cells are promi-
nent in early infection and induce a vascular thickening
and collagen expansion [8].
Arniaud et al. described a case report of coexistent der-
matomyositis, relapsing polychondritis, and positive lyme
serology [5]. Most case reports have described dermato-
myositis in the context of chronic lyme infection
[3,5,9,10]. Dermatomyositis has been described in a for-
est owner with symptoms of dermatomyositis and posi-
tive polymerase chain reaction (PCR) testing for B.
burgdorferi and detection of spirochete organisms in sil-
ver staining [9]. Also dermatomyositis has been diag-
nosed in an immunosupressed patient with seronegative
lyme disease with positive anti Jo 1 autoantibodies and
PCR testing for B. burgdorferi [10].
Less commonly, dermatomyositis has been described
with acute lyme infection (Horowitz et al.), in similarity
to our case presentation [4]. Our case similarly describes
a short time course between time of diagnosis of acute
lyme disease and onset of dermatomyositis. We speculate
that our patient's other underlying medical problems
(specifically malignancy and HCV infection), which may
have acted synergistically with lyme infection to trigger
dermatomyositis.
Amyopathic dermatomyositis and interstitial lung disease
Amyopathic dermatomyositis is characterized by cutane-
ous manifestations, without myositis (normal CPK and
aldolase levels). Euwer et al. first conceptualized that it
may represent one continuum of disease spectrum with
dermatomyositis-polymyositis on the other [11]. A failure
to recognize amyopathic dermatomyositis early in the
absence of myositis may cause considerable delays in
diagnosis, which is relevant because amyopathic dermat-
omyositis may still be associated with life threatening sys-
temic diseases including interstitial pulmonary fibrosis
[12-14]. Our patient's presentation with sequential amyo-
pathic dermatomyositis and severe pulmonary interstitial
Figure 1 Mechanic's hands in a patient with dermatomyositis. Im-
age reprinted with permission from emedicine.com, 2009. Available at: 
http://emedicine.medscape.com/article/1064945-overview
Figure 2 Vacuolar changes of columnar epithelium and lympho-
cytic inflammatory infiltrates at the dermal-epidermal interface 
in dermatomyositis. Image reprinted with permission from emedi-
cine.com, 2009. Available at: http://emedicine.medscape.com/article/
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http://www.jmedicalcasereports.com/content/4/1/187
Page 4 of 5
fibrosis is strengthened by the positive anti-JO1 antibody
testing [13,14].
An alternative explanation to amyopathic dermatomyo-
sitis in this case, which is possible, is that early corticos-
teroid therapy for COPD stymied the emergence of
clinical myositis. Interestingly, some patients with amyo-
pathic dermatomyositis without clinical myositis still
have abnormal findings on ultrasound, magnetic reso-
nance imaging, or muscle biopsy [11,12]. In agreement
with previous authors, we believe that overly strict inter-
pretation of diagnostic criteria may lead to underdiagno-
sis and undertreament of amyopathic dermatomyositis in
some patients who are not evaluated beyond clinical,
immunological and enzymatic studies [11-14]. It is rea-
sonable that given sufficient time, that progression of
untreated lyme infection from acute to chronic stages
may be associated with amyopathic dermatomyositis or
full dermatomyositis-polymyositis [3-5].
Our patient's eventual diagnosis of interstitial pulmo-
nary fibrosis was challenging because his respiratory
complaints were initially largely attributed to COPD
exacerbation. Our patient did not have a history of ILD
and had normal chest radiographs on presentation, and
ILD only ensued following development of the amyo-
pathic dermatomyositis. However, early aggressive ther-
apy with antimicrobials and corticosteroids (fortuitous
treatment for both dermatomyositis and interstitial pul-
monary fibrosis) was not successful in reversing outcome.
Although the association of lyme disease with demato-
myositis, and link of dermatomyositis with interstitial
lung disease are both described, to our knowledge this is
the first case in which lyme disease is then linked to fatal
ILD. Interestingly, in the medical literature, a case has
been reported of lyme disease and respiratory decompen-
sation through diaphgramatic paralysis [15]. Also, Silva et
al. described three cases of acute respiratory failure from
neuroborreliosis, and these patients had encephalopathy
and brainstem abnormalities [16].
Conclusions
Prognosis of dermatomyositis is related to severity of
myopathy, related end organ damage, and coexistent
malignancy [11,12]. Interstitial pulmonary fibrosis is per-
haps the most pertinent and potentially life-threatening
complication associated with amyopathic dermatomyo-
sisits and yet its clinical features are not well understood
[13,14] (Figure 3). Ideura et al. suggested that a subset of
these patients are predisposed to rapid respiratory dec-
ompensation, and need to be identified early to enhance
clinical outcomes [14].
To conclude, we describe a patient with acute lyme
infection who presents with amyopathic dermatomyositis
and rapidly progressive interstitial fibrosis. This case
illustrates a potential for lyme disease to produce clinical
syndromes and fatal complications that may be indistin-
guishable from those observed in primary connective tis-
sue diseases. The corollary of this proposition is that in
patients who are diagnosed with lyme infection who sub-
sequently develop atypical muscular, respiratory or other
systemic complaints, the possibility of severe rheumato-
logical and pulmonary associations should be considered.
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